Published in J Med Screen on January 01, 2012
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Benefits and harms of mammography screening. Breast Cancer Res (2015) 1.22
Mammographic performance in a population-based screening program: before, during, and after the transition from screen-film to full-field digital mammography. Radiology (2014) 0.98
Visualizing typical features of breast fibroadenomas using phase-contrast CT: an ex-vivo study. PLoS One (2014) 0.85
Comparison of cumulative false-positive risk of screening mammography in the United States and Denmark. Cancer Epidemiol (2015) 0.84
Integrating Expert Knowledge with Data in Bayesian Networks: Preserving Data-Driven Expectations when the Expert Variables Remain Unobserved. Expert Syst Appl (2016) 0.82
Increased Risk of Developing Breast Cancer after a False-Positive Screening Mammogram. Cancer Epidemiol Biomarkers Prev (2015) 0.81
Statistical Methods for Estimating the Cumulative Risk of Screening Mammography Outcomes. Cancer Epidemiol Biomarkers Prev (2015) 0.79
False positives in breast cancer screening with one-view breast tomosynthesis: An analysis of findings leading to recall, work-up and biopsy rates in the Malmö Breast Tomosynthesis Screening Trial. Eur Radiol (2016) 0.78
Cumulative risk of false positive test in relation to breast symptoms in mammography screening: a historical prospective cohort study. Breast Cancer Res Treat (2016) 0.77
Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulation. BMC Cancer (2015) 0.77
Women's participation in breast cancer screening in France--an ethical approach. BMC Med Ethics (2014) 0.77
Risk of breast cancer after false-positive results in mammographic screening. Cancer Med (2016) 0.75
Breast carcinoma detection modes and death in a female population in relation to population-based mammography screening. Springerplus (2014) 0.75
Breast cancer risk is increased in the years following false-positive breast cancer screening. Eur J Cancer Prev (2016) 0.75
The genome sequence of the plant pathogen Xylella fastidiosa. The Xylella fastidiosa Consortium of the Organization for Nucleotide Sequencing and Analysis. Nature (2000) 10.03
Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med (2007) 5.57
Effect of population-based screening on breast cancer mortality. Lancet (2011) 5.06
Comparison of screening mammography in the United States and the United kingdom. JAMA (2003) 4.53
The impact of heat waves and cold spells on mortality rates in the Dutch population. Environ Health Perspect (2001) 3.89
The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer (1992) 3.88
Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst (2008) 3.24
European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document. Ann Oncol (2007) 2.84
Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. BMJ (2009) 2.77
Risk factors for cervical cancer in Colombia and Spain. Int J Cancer (1992) 2.75
The contribution of 700,000 ORF sequence tags to the definition of the human transcriptome. Proc Natl Acad Sci U S A (2001) 2.71
European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology (2008) 2.67
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer (2010) 2.62
Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol (1992) 2.60
HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol (2000) 2.60
Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol (1998) 2.49
The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer (2007) 2.48
Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer (2008) 2.41
The histology of solitary renal allografts at 1 and 5 years after transplantation. Am J Transplant (2010) 2.40
Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening. J Natl Cancer Inst (2009) 2.32
Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut (2011) 2.27
Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis. Eur Urol (2005) 2.26
Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids. Aliment Pharmacol Ther (2014) 2.17
Follow-up and final results of the Oslo I Study comparing screen-film mammography and full-field digital mammography with soft-copy reading. Acta Radiol (2005) 2.16
The scalloped gene encodes a novel, evolutionarily conserved transcription factor required for sensory organ differentiation in Drosophila. Genes Dev (1992) 2.03
Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme. Gut (2011) 2.00
Screening and cervical cancer cure: population based cohort study. BMJ (2012) 1.99
Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst (1996) 1.96
EPIC-Germany--A source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition. Ann Nutr Metab (1999) 1.87
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document. Ann Oncol (2010) 1.86
Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. Eur J Cancer (2013) 1.85
Climate change and human health in Europe. BMJ (1999) 1.84
Identification of human chromosome 22 transcribed sequences with ORF expressed sequence tags. Proc Natl Acad Sci U S A (2000) 1.84
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant (2006) 1.83
Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. Br J Cancer (2009) 1.82
Quality and efficiency of bystander CPR. Belgian Cerebral Resuscitation Study Group. Resuscitation (1993) 1.80
Organic solvents and cancer. Cancer Causes Control (1997) 1.79
Digital scanning of histologic sections. Am J Surg Pathol (1999) 1.78
Nramp defines a family of membrane proteins. Proc Natl Acad Sci U S A (1995) 1.78
Lap Band adjustable gastric banding system: the Italian experience with 1863 patients operated on 6 years. Surg Endosc (2002) 1.74
European guidelines for clinical management of abnormal cervical cytology, part 2. Cytopathology (2009) 1.74
Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology (2000) 1.72
Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation. Am J Transplant (2008) 1.70
Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screen (2001) 1.66
Results from the NHS breast screening programme 1990-1993. J Med Screen (1995) 1.64
Total serum cholesterol in relation to psychological correlates in parasuicide. Br J Psychiatry (2000) 1.63
The learning curve in laparoscopic liver resection: improved feasibility and reproducibility. Ann Surg (2009) 1.63
Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes. Proc Natl Acad Sci U S A (2003) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Occupation and larynx and hypopharynx cancer: a job-exposure matrix approach in an international case-control study in France, Italy, Spain and Switzerland. Cancer Causes Control (2003) 1.59
T4 colorectal cancer: is laparoscopic resection contraindicated? Colorectal Dis (2011) 1.56
An asbestos hazard in the reprocessed textile industry. Am J Ind Med (1987) 1.56
Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev (1993) 1.56
Achievable standards, benchmarks for reporting, and criteria for evaluating cervical cytopathology. Second edition including revised performance indicators. Cytopathology (2000) 1.55
The story of the European Randomized Study of Screening for Prostate Cancer. BJU Int (2003) 1.55
Does an organised screening programme reduce the inequalities in breast cancer survival? Ann Oncol (2011) 1.53
Acute pancreatitis in patients with acute hepatic failure. Am J Dig Dis (1973) 1.53
Purification and characterization of a calicivirus as the causative agent of a lethal hemorrhagic disease in rabbits. J Virol (1990) 1.52
Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J Neurol Neurosurg Psychiatry (2011) 1.52
Comparing the performance of mammography screening in the USA and the UK. J Med Screen (2005) 1.52
Performance measures in three rounds of the English bowel cancer screening pilot. Gut (2011) 1.52
Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study. Ann Oncol (2013) 1.52
Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round. Int J Cancer (1997) 1.52
A management approach to incompletely excised basal cell carcinomas of skin. Int J Radiat Oncol Biol Phys (1991) 1.52
Human isoferritins in normal and disease states. Semin Hematol (1977) 1.50
[Concept and implementation of model projects for mammography screening in Germany]. Radiologe (2001) 1.50
Option appraisal of population-based colorectal cancer screening programmes in England. Gut (2006) 1.49
International comparison of performance measures for screening mammography: can it be done? J Med Screen (2004) 1.49
Fluid-fluid membrane microheterogeneity: a fluorescence resonance energy transfer study. Biophys J (2001) 1.47
Restoration of spontaneous circulation after cessation of cardiopulmonary resuscitation. Lancet (1993) 1.47
The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen (2012) 1.46
A pooled analysis of interval cancer rates in six European countries. Eur J Cancer Prev (2010) 1.46
Hyperlipidemia in liver transplant recipients: prevalence and risk factors. Liver Transpl Surg (1997) 1.46
The Diet Habit Survey: a new method of dietary assessment that relates to plasma cholesterol changes. J Am Diet Assoc (1992) 1.45
Apparently balanced de novo translocations in patients with abnormal phenotypes: report of 6 cases. Clin Genet (1977) 1.45
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
The impact of Jade Goody's diagnosis and death on the NHS Cervical Screening Programme. J Med Screen (2012) 1.44
Survival after out-of-hospital cardiac arrest in elderly patients. Belgian Cerebral Resuscitation Study Group. Ann Emerg Med (1992) 1.43
Stenting for in-stent restenosis: A long-term clinical follow-up. Catheter Cardiovasc Interv (1999) 1.43
Potential impact of policy regulation and generic competition on sales of cholesterol lowering medication, antidepressants and acid blocking agents in Belgium. Acta Clin Belg (2012) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Atonal is a proneural gene for a subset of olfactory sense organs in Drosophila. Genes Cells (1997) 1.40
A historical prospective study of European stainless steel, mild steel, and shipyard welders. Br J Ind Med (1991) 1.40
Rapid screening: a comparative study. Cytopathology (2001) 1.40
Anaesthetic management for placement of a stent for high tracheal stenosis. Anaesth Intensive Care (1994) 1.40
Diagnosis of pulmonary emboli and image quality at CT pulmonary angiography: influence of imaging direction with multidetector CT. Clin Radiol (2006) 1.40